This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Prospective, Open-label, Non-controlled, Multicent...
Clinical trial

Prospective, Open-label, Non-controlled, Multicenter, Phase III Clinical Study to Evaluate the Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NEWGAM) in Primary Immune Thrombocytopenia

Read time: 1 mins
Last updated:12th Apr 2011
To assess the efficacy of NewGam in correcting the platelet count.
Category Value
Study start date 2011-04-12

View full details